| |
Welcome |
 |
Immunomic Therapeutics' website is your resource for news & updates about the Company as well a wealth of technical and informational content.
For general information about ITI, its management team and our vision, we invite you to explore the About Us section. If you are interested in learning a little basic immunology and how vaccines can be used to treat allergies, visit our Immunology 101 section. We are also planning on adding a multi-media section to further your understanding of LAMP-vax Technology and our developing vaccine product line.
|
|
About us |
|
Immunomic Therapeutics, Inc. (ITI) is a development stage biotechnology company with exceptional science for application to vaccines and vaccine immunotherapies.
The promise of our LAMP-vax Technology is to increase the effectiveness of the immune response to DNA vaccines while simplifying overall vaccine design and delivery. The LAMP-vax Technology is ideally suited for application to allergy immunotherapy and the company is planning to initiate a clinical study in 2009. There is both industry and clinical validation for this breakthrough science.
|
|
Latest news |
|
May 17th, 2010
Immunomic Therapeutics Announces Frost & Sullivan Award Immunomic Therapeutics has won the 2010 Technology Innovation Award for its work in DNA Vaccines More information is available in our News Section.
March 28th, 2010
Immunomic Therapeutics Announces Closing on $600K Financing Round Immunomics is pleased to announce receipt of investment from the Life Science Greenhouse of Central PA, the Trisiras Group and the Minority Angel Investment Network. For additional news on this event, please visit read the press release.
February 1, 2010
Immunomics opens new offices in Lancaster, PA In a recent press release ITI announce the opening of its new office at Liberty Place in Lancaster and its new laboratory in the Biology Building of Franklin & Marshall College.
|
|
